Development of therapeutic agents for immune-related disorders and inflammation.

NovImmune SA
avenue de la Roseraie 64
1211
Geneva
1211 Geneva
Auf Karte anzeigen
022 839 71 41
022 839 51 05
www.novimmune.com
Öffnungszeiten
MO: 08:00 - 17:00
Firmenbeschrieb
The Mission of NovImmune as a drug development company is to develop new therapeutic agents in the field of immune-related disorders and inflammation. This includes autoimmune diseases and immunosuppression in organ transplantation. NovImmune's applied research relies on internationally recognized scientific excellence in molecular and cellular immuno-biology. Commitment to fully human therapeutic monoclonal antibodies allows NovImmune to move rapidly from the choice of medically relevant targets to the introduction of new therapeutic agents into clinical trials. NovImmune has already demonstrated its ability to deliver its own products into clinical trials in a short time period. NovImmune is the owner of totally novel targets that play a key role in the control of the immune response. These fully validated targets are used by NovImmune for the development of novel classes of low molecular weight inhibitors as anti-inflammatory and immunosuppression agents.Gründungsjahr
2001
Rechtsform
Aktiengesellschaft (AG)
Anzahl Mitarbeiter
32
Umsatz
-
MwSt-Nr
-
Handelsregister
-
Sprachen
English
Zielmärkte
-
Marktleistungen
Noch keine MarktleistungenKernkompetenzen
Noch keine KernkompetenzenKooperationspartner
Noch keine KooperationspartnerKundengruppen
Noch keine KundengruppenReferenzkunden
Noch keine ReferenzkundenZertifikate
Noch keine ZertifikateMitgliedschaften
Noch keine MitgliedschaftenLinks
Noch keine LinksEintrag erstellt: 16.10.2006, Letzte Änderung: 16.10.2006
